Victory Capital Management
LEGN icon

Victory Capital Management’s Legend Biotech LEGN Stock Holding History

Victory Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,959
Closed -$1.21M – 2589
2023
Q3 		$1.21M Buy
17,959
+65
+0.4% +$4.51K ﹤0.01% 1565
2023
Q2 		$1.24M Buy
+17,894
New +$1.17M ﹤0.01% 1560
2022
Q2 		– Sell
-8,464
Closed -$340K – 2729
2022
Q1 		$340K Buy
8,464
+378
+5% +$14.9K ﹤0.01% 2255
2021
Q4 		$377K Buy
+8,086
New +$410K ﹤0.01% 2306

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Victory Capital Management's LEGN Position: Q4 2023 in Review

Victory Capital Management sold out of Legend Biotech (LEGN) in Q4 2023, closing a stake of 17,959 shares — an estimated $1.21M sold.

Victory Capital Management first reported a position in LEGN in Q4 2021 and held it in 4 quarters. The position peaked at $1.24M in Q2 2023. 206 funds tracked by Wall St. Rank hold LEGN as of Q4 2023.

  • Victory Capital Management reported no remaining Legend Biotech position as of Q4 2023 after selling out during the quarter.
  • Victory Capital Management sold 17,959 Legend Biotech shares in Q4 2023, an estimated $1.21M.
  • Victory Capital Management first reported a position in Legend Biotech in Q4 2021 and held it in 4 quarters.
  • Victory Capital Management's Legend Biotech position peaked at $1.24M in Q2 2023.
  • 206 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2023.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.